990WBOB
Menu

RI, Others Reach $71 Million Consumer Settlement with Amgen

8/19/2015

Comments

 
Picture
Rhode Island, along with 48 other states, has reached a $71 million settlement with Amgen Inc. to resolve allegations that Amgen unlawfully promoted biologic medications Aranesp and Enbrel.

 Rhode Island will receive approximately $760,000 as a result of this settlement.

Aranesp is used to treat certain types of anemia by stimulating bone marrow to produce red blood cells. Enbrel is used to treat a number of conditions, including plaque psoriasis. 
The Complaint and Consent Judgment filed today alleges that Amgen violated state consumer protection laws by: (1) promoting Aranesp for dosing frequencies longer than the FDA approved label without competent and reliable scientific evidence to substantiate the extended dosing frequencies; (2) promoting Aranesp for anemia caused by cancer without having FDA approval or competent and reliable scientific evidence to support it; and (3) promoting Enbrel for mild plaque psoriasis even though Enbrel is only approved by the FDA to treat chronic moderate to severe plaque psoriasis.  

"Yet again, a major pharmaceutical company has engaged in deceptive marketing practices, potentially jeopardizing patient health in order to boost their bottom line,” said Attorney General Peter F. Kilmartin. “I will continue to ensure that drug companies comply with the laws in their sales and marketing of drugs to the public. Those laws are designed to protect the safety of patients, and as today’s settlement shows, companies that do not abide by the rules will be held accountable.”

The Consent Judgment also requires Amgen to reform its marketing and promotional practices. For example, under the terms of the Consent Judgment Amgen shall not:


  • make, or cause to be made, any written or oral claim that is false, misleading, or deceptive in promoting Enbrel or any drug in the same class as Aranesp;
  • represent that Enbrel or any drug in the same class as Aranesp has any sponsorship, approval, characteristics, ingredients, uses, benefits, quantities, or qualities that it does not have;
  • use a compendium  listing or publication to promote Enbrel or any drug in the same class as Aranesp for an Off-Label use to a Health Care Professional;
  • allow Amgen Marketing and Amgen Sales to initiate interactions with a compendium or determine the content of any materials for submissions to a compendium relating to Enbrel or any drug in the same class as Aranesp; and
  • submit a Special Supplement to a compendium to support an Off-Label Use of Enbrel or any drug in the same class as Aranesp or use a third party to lobby a compendium on Amgen’s behalf without notifying the compendium that it is acting at Amgen’s request.

The other states participating in the settlement are Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming.

Comments

    WBOB
    Original
    ​Reads

    Picture

    Unbiased, Unfiltered. WBOB's Original Reads feature our brightest and boldest personalities, offering their two-cents on the goings on of news, sports, politics, entertainment, and business. -- Are our opinions always PC? Nope. Are they always perfect? Nah. But, are they always 100% authentic? Absolutely!


    LISTEN
    ​TO WBOB ORIGINAL PODCASTS

    Picture
    Listen to
    ​Past BOBCasts

    WBOB 
    Best Reads
    Brought To You By
    TripAdvisor.com

    Picture

    Celebrating David Clyde: A Wild Passionate Friend To All


    Picture

    Search 
    The Archives


    Reads From Our Friends

    Picture

    The Best Game Development Tools: How to Make Your Own Game

    Picture
    Proud Sponsor of 990WBOB


    Contact Us
    info@990WBOB.com


Search For Your Favorite WBOB Author,
​or BobCast

Featured Supporters

990WBOB 
An Independent Media Outlet.

The views opinions and thoughts expressed do not  reflect those of 990WBOB, its management or its staff. All Rights Reserved 990WBOB.com 2007-2020
​
Contact WBOB HERE

WBOB Reads

Weather

Live BOBCasts

Past Casts

Contact Us

Join Our Team!

Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Photo used under Creative Commons from nzhamstar
  • WBOB READS
  • WBOB Radio
    • The Rotunda
    • RI Red Radio
  • Past Casts
  • Radiothon
  • Weather
  • About
    • Contact
    • WBOB Press Releases
    • Join Our Team!
    • F Bomb Friday
    • CHARITY GALA
  • WBOB READS
  • WBOB Radio
    • The Rotunda
    • RI Red Radio
  • Past Casts
  • Radiothon
  • Weather
  • About
    • Contact
    • WBOB Press Releases
    • Join Our Team!
    • F Bomb Friday
    • CHARITY GALA